PAR 5.00% 19.0¢ paradigm biopharmaceuticals limited..

General OA media and info, page-643

  1. 134 Posts.
    lightbulb Created with Sketch. 50
    Certainly not suggesting we increase our current out goings, but I’d ask the question whether PAR is adequately resourced to meet its self imposed deadlines? Is a lack of resources the reason we can’t meet our submission deadlines and if so I’d much rather we invest in our team and hit those targets rather than spend on overseas roadshows. Clearly the science speaks for itself, and clearly our attempts at self promotion overseas has failed dismally (refer share register and refer pharma of any size showing interest at this stage). All that matters is that the FDA receives quality data and as a shareholder, that the data is delivered as expeditiously as possible…nothing else matters…just FDA approval….the rest will take care of itself and in my opinion pointless spending money anywhere else…
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
(20min delay)
Last
19.0¢
Change
-0.010(5.00%)
Mkt cap ! $66.54M
Open High Low Value Volume
20.0¢ 20.3¢ 18.5¢ $754.5K 3.889M

Buyers (Bids)

No. Vol. Price($)
13 361757 19.0¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 408912 6
View Market Depth
Last trade - 16.10pm 24/09/2024 (20 minute delay) ?
PAR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.